Related Blog Posts from the Wikinvest Wire

Pfizer (PFE)   Subscribe to Pfizer (PFE) content from the Wikinvest Wire
 » Back to Pfizer (NYSE:PFE) Stock Page

  

4/18/14Pfizer Inc (NYSE:PFE) – Pfizer Invites Public to Listen to Webcast of April 24 Annual Meeting o... (Jutia Group)

[Business Wire] - Pfizer Inc. invites investors and the general public to listen to a webcast of the Annual Meeting of Shareholders at 8:30 a.m. on Thursday, April 24. To acc Read more on this. Pfizer Inc. (PFE), currently valued at $193.08B, started the session at $30.19.   Looking at [...]

4/17/14Company Update: Pfizer Inc (NYSE:PFE) – Teva settles patent suit with Pfizer over Celebrex (Jutia Group)

[Reuters] - Teva Pharmaceutical Industries Ltd signed a deal that allows the Israeli drugmaker to launch a generic version of Pfizer Inc's blockbuster painkiller Celebrex in December. A U.S. court in March invalidated a patent extending Pfizer's marketing exclusivity for Celebrex to Dec. 2, 2015. Celebrex's basic chemical patent is set to expire this [...]

3/26/14Company Update (NYSE:PFE): Pfizer Achieves Primary Endpoint With Phase 3B Top-Line Results Of GEN... (Jutia Group)

[Business Wire] - Pfizer Inc. announced today the top-line results from a Phase 3B study evaluating the 24-month efficacy of GENOTROPIN® on the height in small-for-gestational-age children 24-30 months old. Read more on this. Pfizer Inc. (PFE), with a current market cap of $206.42B, opened at $31.97.   During today's [...]

3/25/14Pfizer Inc (NYSE:PFE) | Pfizer Invites Public To View And Listen To Webcast Of May 5 Conference C... (Jutia Group)

[Business Wire] - Pfizer Inc. invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.m. EDT on Monday, May 5, 2014. The purpos Read more on this. Pfizer Inc. (PFE), with a current market cap of $203.10B, opened at $31.77. [...]

3/18/14Market Update (NYSE:PFE): Pfizer Launches 2013 Integrated Annual Review (Jutia Group)

[Business Wire] - Pfizer Inc. today announced the launch of its fourth integrated annual review , which summarizes the company’s 2013 financial, environmental and s Read more on this. Pfizer Inc. (PFE), currently valued at $203.62B, opened at $31.47.   A quick look at the market, the company's traded between [...]

3/12/14Pfizer Inc (NYSE:PFE) – Pfizer Announces Webcast Of April 6 Conference Call With Securities Ana... (Jutia Group)

[Business Wire] - Pfizer Inc. invites investors and the general public to view and listen to a webcast of a presentation by Pfizer’s Oncology leadership on Sunday, April 6, 2014 at 1:30 p.m. Pacific Daylight Time, in connection with the presentation of the final results of the PALOMA-1 Phase 2 trial for palbociclib at [...]

3/5/14 (Jutia Group)

[PR Newswire] - Today, Analysts Review released its analysts' notes regarding Pfizer Inc. (PFE), Dendreon Corp. (DNDN), DepoMed Inc. (DEPO), Globus Medical, Inc. (GMED), and Array BioPharma, Inc. (ARRY). On March 3, 2014, Pfizer Inc.'s (Pfizer) stock decreased 0.40% to end the day at $31.98, compared to the previous day's closing price at $32.11. [...]

2/24/14Pfizer Inc (NYSE:PFE) – Pfizer Announces FDA Approval to Include Radiographic Data on Reduction... (Jutia Group)

[Business Wire] - Pfizer Inc. announced today that the U.S. Food and Drug Administration has approved a supplemental New Drug Application to update the current label of XELJANZ® 5 mg tablets to include radiographic data from two Phase 3 studies, ORAL Scan and ORAL Start . Read more on this. Pfizer Inc. (PFE), [...]

2/21/14Pfizer Inc (NYSE:PFE) – In a Subanalysis, Eliquis® (apixaban) Reduced the Risk of Stroke and D... (Jutia Group)

[Business Wire] - Bristol-Myers Squibb Company and Pfizer Inc. today announced results of a pre-specified subanalysis of the Phase 3 ARISTOTLE trial in relation to patient age. ARISTOTLE was designed to evaluate the efficacy and safety of Eliquis compared to warfarin for reducing the risk of stroke or systemic embolism in patients with nonvalvular [...]

2/18/14Stock Update: Pfizer Inc (NYSE:PFE) – Pfizer Invites Public to View and Listen to Webcast of Pf... (Jutia Group)

[Business Wire] - Pfizer Inc. invites investors and the general public to view and listen to a webcast of a presentation by Mikael Dolsten, President, Worldwide Research and Development, at the Citi 2014 Global Healthcare Conference on Tuesday, February 25, 2014 at 8:50 a.m. Read more on this. Pfizer Inc. (PFE), currently valued [...]

2/14/14Stock Update: Pfizer Inc (NYSE:PFE) – Behind Pfizer’s latest upheaval at the top (Jutia Group)

[at Fortune] - FORTUNE -- Amy Schulman, one of Pfizer's (PFE) star execs and No. 43 on the Fortune Most Powerful Women list, is out of a job. And the irony is that her dismissal comes just as she expected to vault into ... Read more on this. Pfizer Inc. (PFE), with a [...]

2/11/14Stock Update: Pfizer Inc (NYSE:PFE) – Pfizer Statement on Today’s Joint Meeting of FDA Adviso... (Jutia Group)

[Business Wire] - Pfizer agrees with the recommendation of the joint meeting of the FDA Arthritis Advisory Committee and Drug Safety and Risk Management Advisory Committee that the available data do Read more on this. Pfizer Inc. (PFE), with a current market cap of $206.55B, opened at $31.79.   Today, [...]

2/7/14Stock Update: Pfizer Inc (NYSE:PFE) – Will These Two Drugs Turn Around Losses at Pfizer? (Jutia Group)

[at Motley Fool] - Pfizer is working on an experimental drug for breast cancer and expanding use of a pneumonia vaccine to offset losses from patent expirations. Read more on this. Pfizer Inc. (PFE), valued at $202.08B, opened at $30.84.   Looking at the stock, its one day range is [...]

2/6/14Stock Update: Pfizer Inc (NYSE:PFE) – March 14th Options Now Available For Pfizer (PFE) (Jutia Group)

[at TheStreet] - Investors in Pfizer Inc saw new options become available today, for the March 14th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the PFE options chain for the new ... Read more on this. Pfizer Inc. (PFE), currently valued at $199.75B, opened this morning at [...]

2/4/14Stock Update: Pfizer Inc (NYSE:PFE) – Pfizer Among Drugmakers in U.S. Chronic Diseae Project (Jutia Group)

[at Bloomberg] - Pfizer Inc. (PFE) , Eli Lilly & Co. and eight other large drugmakers will partner with the U.S. government in a $230 million effort to identify new approaches to treat Alzheimer’s, diabetes, lupus and arthritis. Data generated from the work will be made public for other scientists to use, a move [...]

2/3/14Company Update: Pfizer Inc (NYSE:PFE) – Pfizer’s new breast cancer drug succeeds in trial (Jutia Group)

[Reuters] - Pfizer Inc's experimental breast cancer drug significantly improved patient survival rates in a mid-stage trial without their condition worsening, maintaining the company's lead in the race for a new treatment standard for the disease. The oral drug, palbociclib, is considered one of Pfizer's most valuable products in development. Palbociclib was designated a [...]

1/28/14Pfizer Inc (NYSE:PFE) | Pfizer Reports Fourth-Quarter and Full-Year 2013 Results; Provides 2014 F... (Jutia Group)

[Business Wire] - Pfizer Inc. reported financial results for fourth-quarter and full-year 2013. As a result of the full disposition of Zoetis on June 24, 2013, the financial results of the Animal Health business are reported as a discontinued operation in the consolidated statements of income for full-year 2013, and fourth-quarter and full-year 2012. [...]

1/27/14Stock Update: Pfizer Inc (NYSE:PFE) – Pfizer lung cancer drug fails in two large studies (Jutia Group)

[Reuters - UK Focus] - Pfizer Inc on Monday said one of its experimental drugs had failed to meet its goals in two late-stage studies among patients who had received prior treatment for advanced non-small cell lung cancer, the ... Read more on this. Pfizer Inc. (PFE), with a current market cap of [...]

1/23/14Company Update: Pfizer Inc (NYSE:PFE) – Pfizer Earnings Preview: Cost-Cutting To Offset Patent ... (Jutia Group)

[at Forbes] - In terms of therapeutic areas, we expect cancer drugs to do well, as the pressure on cardiovascular sales continues. Geographically speaking, emerging markets will be in focus due to the expected volume growth driven by sales of Prevenar. Read more on this. Pfizer Inc. (PFE), with a current market cap [...]

1/22/14Pfizer Inc (NYSE:PFE) – What to Look for When Pfizer Inc. Reports Earnings (Jutia Group)

[at Motley Fool] - Pfizer's upcoming earnings call is likely to be followed by a wave of commotion. Here are some key factors you can listen in for to draw your own opinion. Read more on this. Pfizer Inc. (PFE), with a current market cap of $202.66B, opened at $31.31.   [...]

1/21/14Pfizer Inc (NYSE:PFE) | Correction: Pfizer likely to report strong trial results, says BMO Capital (Jutia Group)

[theflyonthewall.com] - BMO Capital believes that the results of trials of Pfizer's CAPITA and PALOMA-1 drugs are very likely to be positive. The firm recommends buying the stock ahead of clinical results of trials of the drugs. ... Read more on this. Pfizer Inc. (PFE), valued at $202.60B, ended session yesterday at $31.09. [...]

1/17/14New Way to Make Big Money in Biotech Stocks Sector (Gold Stocks Today)

Ernie Tremblay writes: Traditional pharmaceutical blockbusters like Pfizer's Lipitor treat millions of patients at relatively low cost. It's a high-volume business model that has kept the pharmaceutical industry afloat for a long, long time. ...

1/17/14Pfizer Inc. (NYSE:PFE) | Statement from Pfizer Chief Medical Officer on the 50th Anniversary of t... (Jutia Group)

[Business Wire] - Freda Lewis-Hall, M.D., Pfizer’s executive vice president and chief medical officer, today issued a statement regarding the 50th Anniversary of the First Surgeon General's Report o Read more on this. Pfizer Inc. (PFE), valued at $201.37B, opened this morning at $31.25.   Looking at today's market, PFE [...]

1/8/14Stock Update: Pfizer Inc. (NYSE:PFE) – Can 2014′s Riskiest Big Pharma Stock Launch a Comeback? (Jutia Group)

[at Motley Fool] - Eli Lilly missed the 2013 rally that propelled big pharma stocks like Pfizer and AstraZeneca. Can this company beat the patent cliff in the long term and turn things around for disappointed investors? Read more on this. Pfizer Inc. (PFE), valued at $200.07B, began trading this morning at $30.78. [...]

1/1/14Company Update: Pfizer Inc. (NYSE:PFE) – China Puts the Brakes on Imports of Pfizer’s Diflucan (Jutia Group)

[at Wall St. Cheat Sheet] - China's FDA has suspended imports of the Pfizer medication Diflucan following the company's failure to submit the appropriate paperwork on time. Read more on this. Pfizer Inc. (PFE), with a current value of $198.52B, opened at $30.62.   Looking at the equity, the company's [...]

12/20/13Eli Lilly and Company (NYSE:LLY) | Pfizer’s Expiring Viagra Patent Adversely Affects Other Drug... (Jutia Group)

[at Forbes] - By David J. Phillips Looking ahead, the sex business isn’t expected to be as profitable as it once was for Pfizer, Eli Lilly (LLY) and Bayer AG, manufacturers of Viagra, Cialis and Levitra, respectively, the three top-selling oral drugs taken by men worldwide for erectile dysfunction (ED). Owing to generic intrusion, [...]

12/20/13Pfizer Inc. (NYSE:PFE) – Pfizer’s Expiring Viagra Patent Adversely Affects Other Drugmakers Too (Jutia Group)

[at Forbes] - By David J. Phillips Looking ahead, the sex business isn’t expected to be as profitable as it once was for Pfizer, Eli Lilly (LLY) and Bayer AG, manufacturers of Viagra, Cialis and Levitra, respectively, the three top-selling oral drugs taken by men worldwide for erectile dysfunction (ED). Owing to generic intrusion, [...]

12/18/13Company Update – Pfizer Inc. (NYSE:PFE) – Magnetar Capital starts new positions in DNR, OKE, ... (Jutia Group)

[Market Realist] - In this six-part series, we’ll go through some of the main positions Magnetar traded this past quarter. Why buy Kinder Morgan Inc. (KMI)? Read more on this. Pfizer Inc. (PFE), with a current market cap of $197.87B, opened at $30.28.   Today’s price range has been between [...]

12/17/13Pfizer Inc. (NYSE:PFE) – Pfizer Invites Public To View And Listen To Webcast Of January 28 Conf... (Jutia Group)

[Business Wire] - Pfizer Inc. invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.m. EST on Tuesday, January 28, 2014. The Read more on this. Pfizer Inc. (PFE), with a current market cap of $195.24B, started trading this morning [...]

12/16/13Pfizer Inc. (NYSE:PFE) ~ Pfizer Declares First-Quarter 2014 Dividend (Jutia Group)

[Business Wire] - The board of directors of Pfizer Inc. today declared a 26-cent first-quarter 2014 dividend on the company’s common stock, payable March 4, 2014, to shareholders of record at the close of business on February 7, 2014. Read more on this. Pfizer Inc. (PFE), currently valued at $196.18B, opened this morning [...]

12/10/13Pfizer Inc. (NYSE:PFE) – Morning Dow Report: Pfizer, Coca-Cola Stumble as Goldman and JPMorgan ... (Jutia Group)

[at Motley Fool] - The Dow was little changed this morning, with industry-specific positive news sending Goldman Sachs and JPMorgan Chase higher even as defensive stocks Pfizer and Coca-Cola fell. Find out what moved the ... Read more on this. Pfizer Inc. (PFE), with a current market cap of $203.18B, opened this morning [...]

12/9/13Pfizer Inc. (NYSE:PFE) | U.S. justices leave intact Neurontin verdict against Pfizer (Jutia Group)

[Reuters] - The U.S. Supreme Court said on Monday it would leave intact a $142 million jury verdict against Pfizer Inc over its marketing of the epilepsy drug Neurontin. A jury in Massachusetts found in 2010 that ... Read more on this. Pfizer Inc. (PFE), currently valued at $204.96B, began trading this morning [...]

12/6/13Pfizer Inc. (NYSE:PFE) | Are there animal spirits in Zoetis? (Jutia Group)

[optionMONSTER] - Zoetis was spun off from Pfizer early this year, and one big investor thinks the animal spirits are ready to take over. optionMONSTER's Heat Seeker monitoring program detected the purchase of 3,000 July ... Read more on this. Pfizer Inc. (PFE), with a current value of $203.89B, began trading this morning [...]

12/5/13Pfizer Inc. (NYSE:PFE) | Pfizer And GlaxoSmithKline: Aiming For Melanoma Cure Supremacy (Jutia Group)

[at Seeking Alpha] - To enhance the safety and efficacy profile of its probable future blockbuster cancer drug, "Palbociclib," Pfizer ( PFE ) collaborated with GlaxoSmithKline ( GSK ) . The company will evaluate ... Read more on this. Pfizer Inc. (PFE), with a current market cap of $202.34B, opened this morning at [...]

12/4/13Pfizer Inc. (NYSE:PFE) ~ Pfizer Expands Clinical Trial Data Access Policy And Launches Data Acces... (Jutia Group)

[Business Wire] - Pfizer Inc. today announced an update of its clinical trial data access policy that will simplify and broaden access to information gathered in Pfizer-sponsored clinical trials. Read more on this. Pfizer Inc. (PFE), with a current value of $202.37B, opened this morning at $31.11.   Looking at [...]

12/3/13Pfizer Inc. (NYSE:PFE) ~ Dow Today: Pfizer (PFE) Lower (Jutia Group)

[at TheStreet] - Holding back the Dow today is Pfizer (NYSE: PFE ), which is lagging the broader Dow index with a 46-cent decline (-1.5%) bringing the stock to $31.36. Read more on this. Pfizer Inc. (PFE), with a current market cap of $202.73B, began trading this morning at $31.69. Looking [...]

12/2/13Stock Update: Pfizer Inc. (NYSE:PFE) – Pfizer Acquires Polocard, Poland’s Leading Over-The-Co... (Jutia Group)

[Business Wire] - Pfizer Inc. today announced that a wholly-owned Polish subsidiary of Pfizer has acquired the rights to Polocard, a low-dose aspirin , and the l Read more on this. Pfizer Inc. (PFE), currently valued at $205.97B, opened this morning at $31.61. Looking at today's market, PFE one day range [...]

11/28/13Company Update: Pfizer Inc. (NYSE:PFE) – Will This Top Dow Health-Care Stock Stay Healthy in 2014? (Jutia Group)

[at Motley Fool] - Pfizer's boomed in 2013, and with the patent cliff's worries beginning to subside, the stock could be ready to keep rolling in the new year. Read more on this. Pfizer Inc. (PFE), valued at $206.62B, began trading this morning at $32.02. A quick look at the market, [...]

11/26/13Stock Update: Pfizer Inc. (NYSE:PFE) – Pain Therapeutics: Very Substantial Risk-Adjusted Upside... (Jutia Group)

[at Seeking Alpha] - Pain Therapeutics Inc. ( PTIE ) is a drug development company that will collect roughly a 20% U.S. royalty and a 10% foreign royalty on what I estimate to be $1.4 billion/year in sales if Pfizer ( PFE ... Read more on this. Pfizer Inc. (PFE), currently valued at [...]

11/25/13Company Update: Pfizer Inc. (NYSE:PFE) – Pfizer to Wed Indian Operations and Wyeth’s India Unit (Jutia Group)

[at Wall St. Cheat Sheet] - Pfizer Inc. will be merging its Indian units Pfizer Ltd. and Wyeth Ltd. in a move that's been a long time coming. Read more on this. Pfizer Inc. (PFE), valued at $210.04B, started trading this morning at $32.18. Looking at today's market, PFE one day [...]

11/21/13Pfizer Inc. (NYSE:PFE) | Pfizer and GSK to Initiate Study of Novel Combination Therapy in Patient... (Jutia Group)

[Business Wire] - Pfizer Inc. announced today that it has entered into an agreement with GSK to explore the anti-cancer efficacy and the safety of GSK’s trametinib combined with Pfizer’ Read more on this. Pfizer Inc. (PFE), valued at $207.20B, started trading this morning at $31.85. Looking at the equity, the [...]

11/18/13Pfizer Inc. (NYSE:PFE) – September 2014 Options Now Available For Pfizer (PFE) (Jutia Group)

[at Forbes] - Investors in Pfizer Inc (NYSE: PFE) saw new options become available today, for the September 2014 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 306 days until expiration the newly available contracts represent [...] [...]

11/15/13Stock Update: Pfizer Inc. (NYSE:PFE) – Pfizer to Employees: Dump Your BlackBerry Devices (Jutia Group)

[at Wall St. Cheat Sheet] - Pfizer has told its employees to stop using BlackBerry smartphones and switch to a device made by Apple or one running on Google's Android operating system. Read more on this. Pfizer Inc. (PFE), currently valued at $212.25B, opened this morning at $31.83. During the trading [...]

11/14/13Pfizer Inc. (NYSE:PFE) | Pfizer Subsidiary, Wyeth LLC, To Redeem 5.500% Notes Due February 1, 2014 (Jutia Group)

[Business Wire] - Pfizer Inc. today announced that Wyeth LLC, its wholly owned subsidiary, has notified The Bank of New York Mellon, as trustee under the applicable indenture, of its election to fully redeem all of its outstanding 5.500% Notes due February 1, 2014 (CUSIP No. Read more on this. Pfizer Inc. (PFE), [...]

11/11/13Company Update – Pfizer Inc. (NYSE:PFE) – Interesting PFE Put And Call Options For January 2016 (Jutia Group)

[at Forbes] - Investors in Pfizer Inc (NYSE: PFE) saw new options become available today, for the January 2016 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 795 days until expiration the newly available contracts represent [...] [...]

11/8/13Pfizer Inc. (NYSE:PFE) | Pfizer Announces Top-Line Results Of Phase 3B/4 Study Of RAPAMUNE® (sir... (Jutia Group)

[Business Wire] - Pfizer Inc. announced today top-line results from a Phase 3B/4 study of RAPAMUNE® evaluating kidney transplant patients who transitioned from tacrolimus-based therapy to RAPAMUNE® 3 to 5 months after transplant. Read more on this. Pfizer Inc. (PFE), with a current value of $205.23B, started the session at $30.88. [...]

11/5/13Stock Update: Pfizer Inc. (NYSE:PFE) – Merck Seen Unlocking $13 Billion With Breakup: Real M&A (Jutia Group)

[at Bloomberg] - Merck & Co., the second-biggest U.S. drugmaker, may be coming around to the idea of separating its businesses after the breakup of larger rival Pfizer Inc. boosted shareholder value by $50 billion. Read more on this. Pfizer Inc. (PFE), valued at $206.88B, started trading this morning at $31.19. [...]

11/4/13Stock Update: Pfizer Inc. (NYSE:PFE) – Vertex Failure Shows Biotech Is Not Immune To Big Pharma... (Jutia Group)

[at Forbes] - Vertex is a good company and I think they will have success in their new waterfront buildings. But they are faced with the same question that Merck, Pfizer and the other big pharmas face: “What’s in your pipeline?”. Read more on this. Pfizer Inc. (PFE), with a current value of [...]

10/31/13Pfizer Vs. Novartis: A New Era In Breast Cancer Treatment – Pfizer Inc. (NYSE:PFE) (Jutia Group)

[at Seeking Alpha] - Pfizer ( PFE ) has high hopes for its experimental breast cancer drug palbociclib (PD-0332991), an oral inhibitor of CDK (cyclin-dependent kinases) 4 and 6. The therapy generated excitement among oncologists ... Read more on this. Pfizer Inc. (PFE), valued at $203.64B, opened this morning at $30.78. [...]

10/29/13Pfizer 3rd-qtr profit beats estimates; oncology drugs shine – Pfizer Inc. (NYSE:PFE) (Jutia Group)

[Reuters] - Pfizer Inc reported better-than-expected third-quarter earnings on Tuesday, helped by costs cuts and growing sales of recently approved cancer medicines. The largest U.S. drugmaker said it earned $2.59 ... Read more on this. Pfizer Inc. (PFE), currently valued at $206.02B, opened at $30.84. A quick look at the market, the company's traded [...]


Your blog posts can appear here by joining the Wikinvest Wire
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki